BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33304903)

  • 1. Down-Regulation of PDCD4 Promotes Proliferation, Angiogenesis and Tumorigenesis in Glioma Cells.
    Pin G; Huanting L; Chengzhan Z; Xinjuan K; Yugong F; Wei L; Shifang L; Zhaojian L; Kun H; Weicheng Y; Yingying L; Yongming Q; Yanan Y
    Front Cell Dev Biol; 2020; 8():593685. PubMed ID: 33304903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDCD4 Deficiency Aggravated Colitis and Colitis-associated Colorectal Cancer Via Promoting IL-6/STAT3 Pathway in Mice.
    Wang L; Zhao M; Guo C; Wang G; Zhu F; Wang J; Wang X; Wang Q; Zhao W; Shi Y; Chen YH; Zhang L
    Inflamm Bowel Dis; 2016 May; 22(5):1107-18. PubMed ID: 26891257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells.
    Dikshit B; Irshad K; Madan E; Aggarwal N; Sarkar C; Chandra PS; Gupta DK; Chattopadhyay P; Sinha S; Chosdol K
    Oncogene; 2013 Aug; 32(33):3798-808. PubMed ID: 22986533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth.
    Shiota M; Izumi H; Tanimoto A; Takahashi M; Miyamoto N; Kashiwagi E; Kidani A; Hirano G; Masubuchi D; Fukunaka Y; Yasuniwa Y; Naito S; Nishizawa S; Sasaguri Y; Kohno K
    Cancer Res; 2009 Apr; 69(7):3148-56. PubMed ID: 19318582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
    Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
    Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of PDCD4 mediated by the long non-coding RNA HOTAIR inhibits the proliferation and invasion of glioma cells.
    Chen Y; Bian Y; Zhao S; Kong F; Li X
    Oncol Lett; 2016 Dec; 12(6):5170-5176. PubMed ID: 28105224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation.
    Cui H; Wang Q; Lei Z; Feng M; Zhao Z; Wang Y; Wei G
    J Exp Clin Cancer Res; 2019 Aug; 38(1):350. PubMed ID: 31409387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atg7 senses ATP levels and regulates AKT
    Deng C; Li C; Dong X; Yu Y; Guo W; Guan Y; Sun X; Cao L
    Commun Biol; 2023 Dec; 6(1):1252. PubMed ID: 38081915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer.
    Cuesta R; Holz MK
    Oncotarget; 2016 May; 7(19):27567-83. PubMed ID: 27028868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of tumor growth in xenograft model mice by programmed cell death 4 gene delivery using folate-PEG-baculovirus.
    Kim YK; Kwon JT; Choi JY; Jiang HL; Arote R; Jere D; Je YH; Cho MH; Cho CS
    Cancer Gene Ther; 2010 Nov; 17(11):751-60. PubMed ID: 20539318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma.
    Gao F; Zhang P; Zhou C; Li J; Wang Q; Zhu F; Ma C; Sun W; Zhang L
    Oncol Rep; 2007 Jan; 17(1):123-8. PubMed ID: 17143488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion.
    Schmid T; Jansen AP; Baker AR; Hegamyer G; Hagan JP; Colburn NH
    Cancer Res; 2008 Mar; 68(5):1254-60. PubMed ID: 18296647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDCD4 inhibits lung tumorigenesis by the suppressing p62-Nrf2 signaling pathway and upregulating Keap1 expression.
    Hwang SK; Jeong YJ; Chang YC
    Am J Cancer Res; 2020; 10(2):424-439. PubMed ID: 32195018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Pdcd4 in tumour suppression and protein translation.
    Wang Q; Yang HS
    Biol Cell; 2018 May; ():. PubMed ID: 29806708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knock-down of Pdcd4 stimulates angiogenesis via up-regulation of angiopoietin-2.
    Krug S; Huth J; Göke F; Buchholz M; Gress TM; Göke R; Lankat-Buttgereit B
    Biochim Biophys Acta; 2012 Apr; 1823(4):789-99. PubMed ID: 22289349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PDCD4/miR-21 pathway in medullary thyroid carcinoma.
    Pennelli G; Galuppini F; Barollo S; Cavedon E; Bertazza L; Fassan M; Guzzardo V; Pelizzo MR; Rugge M; Mian C
    Hum Pathol; 2015 Jan; 46(1):50-7. PubMed ID: 25316501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma.
    Wang Q; Zhu J; Wang YW; Dai Y; Wang YL; Wang C; Liu J; Baker A; Colburn NH; Yang HS
    Oncogene; 2017 Nov; 36(45):6225-6234. PubMed ID: 28692058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway.
    Fan B; Jin Y; Zhang H; Zhao R; Sun M; Sun M; Yuan X; Wang W; Wang X; Chen Z; Liu W; Yu N; Wang Q; Liu T; Li X
    Int J Oncol; 2020 Jan; 56(1):178-192. PubMed ID: 31789394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Pdcd4 tumor suppressor in human melanoma cells.
    Vikhreva PN; Korobko IV
    Anticancer Res; 2014 May; 34(5):2315-8. PubMed ID: 24778037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.